-
Democrats, Trump hold final rallies before midterm elections
-
African players in Europe: Defender Hakimi's historic hat-trick
-
Japan urges US to enforce discipline after second Marine arrest
-
Struggling Slavia face Arsenal as grim record looms
-
'Remarkable' rookie Lendeborg scores 37 as Warriors beat Clippers
-
Vikings suffer first loss while Broncos edge Chiefs in NFL
-
ExxonMobil urged to re-think Papua New Guinea gas project
-
South Korea to double spending on AI and chips in 2027
-
Asian stocks mixed as tech sector struggles to rebound from selloff
-
On All Saints' Day, Philippine mountain town honours dead with fire
-
India's royals find new power in their past
-
Years on from fall of IS, French jihadists face justice in Iraq
-
Irish bookshops help meet UK demand for Sally Rooney novels
-
Point of Law favourite at Australia's 'race that stops a nation'
-
NFL Vikings suffer first loss while Broncos edge Chiefs
-
'Kid' Antonelli gets affectionate tributes from all quarters
-
Host of fresh faces in Australia white-ball squads to face England
-
Hamilton accuses Leclerc of wrecking Ferrari hopes
-
NFL linebacker Campbell to remain hospitalized overnight
-
Palo Alto Collaboration Company Opens Waitlist for Pana, a Personal AI That Builds Tools That Stay Yours
-
XCF Global Withdraws Reverse Stock Split Proposal; Reaffirms Growth Strategy and Shareholder Support
-
Gladstone Commercial Corporation Earnings Call and Webcast Information
-
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
-
Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service Strategy
-
Anthony, Linder & Cacomanolis Recognized in Chambers & Partners Spotlight Florida 2027 for Securities Law Excellence
-
Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
-
IRS Pushes Tax Deadlines to February 1, 2027 for Washington Wildfire Counties - Clear Start Tax Explains What the Postponement Does Not Pause
-
Optimistivity Unveils Refreshed Brand and Expanded Digital Product Range
-
GameSquare to Report Q3 2026 Financial Results on November 16, 2026
-
AsiaFIN Holdings Corp. to Host Q3 2026 Earnings Webcast from New York City
-
Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
-
Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
-
iAsk.ai Surpasses One Billion Searches
-
International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
-
Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
-
BEING rather than HAVING. A fascinating, practical STORY.
-
Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test
-
Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
-
Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
Aer Lingus and MTech Mobility Launch Live Ground Operations Technology Programme Across Three Irish Airports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 02
-
Proven IT Announces a Partnership with Atom Cybersecurity to Deliver Specialized Cybersecurity Expertise and Enhanced Protection for Businesses
-
Nexscient Announces Expanded Customer Engagements and New Commercial Agreements in Autonomous Driving and Humanoid Robotics Data Services
-
Marijuana Rescheduling In Peril: AMA Demands FDA Scientific Standards As GAO Report Exposes Malaise
-
QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
-
OSR Health Board Authorizes Management to Engage with Potential Acquirer of OSRK for Reverse Takeover
-
PPX Mining Initiates Operating Permit Process for Igor Processing Plant
-
Menhaden "Miss the Target" Soundbite Leaves Out the Full Story
-
QuickMD Names Omar Manejwala, M.D. as Chief Medical Officer
Aeluma Provides Second Quarter of Fiscal Year 2025 Results and Raises Revenue Guidance
Reports Record Second Quarter with Revenue Growth over 500%
Raises Revenue Outlook for Fiscal Year 2025 by 10%
GOLETA, CA / ACCESS Newswire / February 10, 2025 / Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for mobile, automotive, AI, defense & aerospace, communication and quantum computing, today provided a corporate update and announced financial results for the second quarter of fiscal 2025, which ended December 31, 2024.
Recent Company Highlights
Record Revenue: Recognized record high quarterly revenue of $1.6 million, growing over 500% year-over-year, reflecting continued strategic growth across government and commercial contracts
NASA Contract Announcement: Secured NASA contract to advance quantum dot photonic integrated circuits for aerospace and AI applications
Growing Revenue Backlog: Strengthened revenue pipeline through multiple high-impact government and commercial agreements
Silicon Photonics Momentum: Joined AIM Photonics as full industry member in an effort to accelerate quantum dot laser technology for silicon photonics
Intellectual Property Expansion: Filed two new patent applications for quantum computing and sensing
Optica Membership and Leadership: Announced Optica corporate membership and CEO Jonathan Klamkin's Industry Vice Chair role the Advanced Photonics Congress
Magazine Article Publication: Published article in Compound Semiconductor Magazine highlighting Aeluma's scalable, high-performance semiconductor technology
Media Appearance:CEO Jonathan Klamkin appeared on Schwab Network to discuss semiconductor advancements for AI, Quantum Computing and Sensing
Technical Milestone Achieved: Completed a key technical milestone for an ongoing commercial development contract
New Contract Negotiations: Entered negotiations for additional development contracts with potential to be executed within the next fiscal quarter
SPIE Photonics West Showcase: Highlighted innovative technologies at SPIE Photonics West Exhibition in San Francisco, California
Management Commentary
"Aeluma's second-quarter performance underscores the potential for our high-performance semiconductor technologies, with revenue reaching $1.6 million, driven by strategic execution of government and commercial contracts," said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. "Our advancements in quantum dot photonic circuits and scalable sensing solutions position us as a leader in next-generation applications across AI, quantum computing, aerospace & defense, AR/VR, automotive, health, and mobile. With a strong IP portfolio and ongoing momentum, we are focused on scaling our business to meet the evolving needs of dynamic, high-growth markets."
Financial Results
For the quarter ended December 31, 2024, revenue was $1.6 million, compared to $263 thousand in the same quarter last year, and $481 thousand in the prior quarter.
The company incurred a net loss of $2.9 million, or ($0.24) per basic and diluted share, for the quarter ended December 31, 2024, compared to a net loss of $1.1 million, or ($0.09) per basic and diluted share, for the same quarter last year, and a net loss of $730 thousand, or ($0.06) per basic and diluted share, in the prior quarter. Non-GAAP income was $546 thousand for the quarter ended December 31, 2024.
Adjusted EBITDA for the quarter ended December 31, 2024 was $648 thousand, compared to ($924) thousand for the same quarter last year, and ($457) thousand in the prior quarter.
The Company had $3.1 million in cash and cash equivalents as of December 31, 2024, compared to $3.5 million as of September 30, 2024 and $2.4 million as of December 31, 2023.
The total number of shares outstanding was 12,242,481 as of December 31, 2024.
Revenue Guidance
For the full year of fiscal 2025, Aeluma now expects revenue of approximately $4.4-4.6 million, a 10% increase from its previous guidance provided on September 24, 2024. This upward revision reflects confidence in the company's growth trajectory, supported by strong contract performance and expanding market opportunities.
These statements are forward looking and actual results may differ materially. Refer to the Forward-Looking Statements section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.
Note about Non-GAAP Financial Measures
This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma's ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma's results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.
This press release includes non-GAAP financial measures, including:
Non-GAAP net income, which is defined as GAAP net loss plus stock-based compensations, amortization of discount on convertible notes and changes in fair value of derivative liabilities; and
Adjusted EBITDA, defined as non-GAAP net loss plus depreciation and amortization expenses, less interest income.
A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.
About Aeluma, Inc.
Aeluma (www.aeluma.com) develops novel optoelectronics for sensing and communication applications. Aeluma has pioneered a technique to manufacture semiconductor chips using high-performance compound semiconductor materials on large-diameter substrates that are commonly used for mass-market microelectronics. The technology has the potential to enhance performance and scale manufacturing, both of which are critical for emerging applications. Aeluma is developing a streamlined business model from its headquarters in Santa Barbara, California that has a state-of-the-art manufacturing cleanroom. Its transformative semiconductor chip technology may impact a variety of markets including automotive LiDAR, mobile, defense & aerospace, AR/VR, AI, quantum, and communication. Aeluma differentiates itself with unique semiconductor manufacturing capability, proprietary technology, the ability to perform rapid prototyping, and a broad set of product offerings.
Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expect," "intend," "plan," "project," "believe," "estimate," and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.
Company
Aeluma, Inc.
(805) 351-2707
[email protected]
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
[email protected]
Aeluma, Inc. and Subsidiary
Consolidated Balance Sheets (unaudited)
December 31, 2024 | September 30, 2024 | December 31, 2023 | ||||
Assets | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | 3,063,059 | $ | 3,502,520 | $ | 2,423,054 |
Accounts receivable | 1,324,632 | 322,189 | 192,992 | |||
Deferred compensation, current portion | 6,171 | 13,152 | 27,925 | |||
Prepaids and other current assets | 136,307 | 189,129 | 155,647 | |||
Total current assets | 4,530,169 | 4,026,990 | 2,799,618 | |||
Property and equipment: | ||||||
Equipment | 1,572,291 | 1,533,131 | 1,373,946 | |||
Leasehold improvements | 546,864 | 546,864 | 546,864 | |||
Accumulated depreciation | (809,436 | ) | (708,005 | ) | (430,728 | ) |
Property and equipment, net | 1,309,719 | 1,371,990 | 1,490,082 | |||
Intangible assets | 5,333 | 6,083 | 8,333 | |||
Right of use asset - facility | 899,623 | 930,782 | 1,012,342 | |||
Deferred compensation, long term portion | - | - | 6,171 | |||
Other assets | 13,014 | 13,014 | 13,014 | |||
Total assets | $ | 6,757,858 | $ | 6,348,859 | $ | 5,329,560 |
Liabilities and stockholders' equity | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 182,932 | $ | 238,100 | $ | 162,823 |
Accrued expenses and other current liabilities | 172,414 | 215,288 | 163,900 | |||
Lease liability, current portion | 133,460 | 131,090 | 124,145 | |||
Total current liabilities | 488,806 | 584,478 | 450,868 | |||
Lease liability, long term portion | 873,276 | 907,407 | 1,006,736 | |||
Derivative liabilities | 5,048,174 | 2,046,695 | - | |||
Convertible notes, net | 1,379,690 | 1,096,646 | - | |||
Total liabilities | 7,789,946 | 4,635,226 | 1,457,604 | |||
Commitments and contingencies | - | - | - | |||
Stockholders' equity: | ||||||
Preferred stock | - | - | - | |||
Common stock | 1,224 | 1,218 | 1,217 | |||
Additional paid-in capital | 16,215,492 | 16,066,395 | 15,543,634 | |||
Accumulated deficit | (17,248,804 | ) | (14,353,980 | ) | (11,672,895 | ) |
Total stockholders' equity | (1,032,088 | ) | 1,713,633 | 3,871,956 | ||
Total liabilities and stockholders' equity | $ | 6,757,858 | $ | 6,348,859 | $ | 5,329,560 |
Aeluma, Inc. and Subsidiary
Consolidated Statements of Operations (unaudited)
Three Months Ended | Six Months Ended | ||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||
Revenue | $ | 1,612,519 | $ | 480,735 | $ | 262,992 | $ | 2,093,254 | $ | 295,392 | |||||
Operating expenses: | |||||||||||||||
Cost of revenue | 584,549 | 314,575 | 136,767 | 899,124 | 151,906 | ||||||||||
Research and development | 268,061 | 401,074 | 651,099 | 669,135 | 1,485,968 | ||||||||||
General and administrative | 370,311 | 496,466 | 603,925 | 866,777 | 1,269,028 | ||||||||||
Total expenses | 1,222,921 | 1,212,115 | 1,391,791 | 2,435,036 | 2,906,902 | ||||||||||
Loss from operations | 389,598 | (731,380 | ) | (1,128,799 | ) | (341,782 | ) | (2,611,510 | ) | ||||||
Other income (expense): | |||||||||||||||
Interest income | 101 | 102 | 279 | 203 | 681 | ||||||||||
Amortization of discount on convertible notes | (283,043 | ) | (144,776 | ) | - | (427,819 | ) | - | |||||||
Changes in fair value of derivative liabilities | (3,001,480 | ) | 146,435 | - | (2,855,045 | ) | - | ||||||||
Total other income (expense), net | (3,284,422 | ) | 1,761 | 279 | (3,282,661 | ) | 681 | ||||||||
Loss before income tax expense | (2,894,824 | ) | (729,619 | ) | (1,128,520 | ) | (3,624,443 | ) | (2,610,829 | ) | |||||
Income tax expense | - | - | - | - | - | ||||||||||
Net loss | $ | (2,894,824 | ) | $ | (729,619 | ) | $ | (1,128,520 | ) | $ | (3,624,443 | ) | $ | (2,610,829 | ) |
Net loss per share - basic and diluted | $ | (0.24 | ) | $ | (0.06 | ) | $ | (0.09 | ) | $ | (0.30 | ) | $ | (0.21 | ) |
Book value per share | $ | (0.08 | ) | $ | 0.14 | $ | 0.32 | $ | (0.08 | ) | $ | 0.32 | |||
Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Net Income (Loss) (unaudited)
Three Months Ended | Six Months Ended | ||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||
GAAP net loss | $ | (2,894,824 | ) | $ | (729,619 | ) | $ | (1,128,520 | ) | $ | (3,624,443 | ) | $ | (2,610,829 | ) |
Non-GAAP adjustments: | |||||||||||||||
Stock-based compensation - stock option | 149,103 | 167,091 | 135,919 | 316,194 | 376,496 | ||||||||||
Consulting and advisory - restricted stock award | 6,981 | 6,981 | 6,981 | 13,962 | 18,938 | ||||||||||
Amortization of discount on convertible notes | 283,043 | 144,776 | - | 427,819 | - | ||||||||||
Changes in fair value of derivative liabilities | 3,001,480 | (146,435 | ) | - | 2,855,045 | - | |||||||||
Total adjustments to GAAP net loss | 3,440,607 | 172,413 | 142,900 | 3,613,020 | 395,434 | ||||||||||
Non-GAAP net income (loss) | $ | 545,783 | $ | (557,206 | ) | $ | (985,620 | ) | $ | (11,423 | ) | $ | (2,215,395 | ) | |
Depreciation & amortization | 102,181 | 100,125 | 61,999 | 202,306 | 131,783 | ||||||||||
Interest income | (101 | ) | (102 | ) | (279 | ) | (203 | ) | (681 | ) | |||||
Adjusted EBITDA | $ | 647,863 | $ | (457,183 | ) | $ | (923,900 | ) | $ | 190,680 | $ | (2,084,293 | ) | ||
GAAP net loss per share - basic and diluted | $ | (0.24 | ) | $ | (0.06 | ) | $ | (0.09 | ) | $ | (0.30 | ) | $ | (0.21 | ) |
Non-GAAP adjustments | 0.28 | 0.01 | 0.01 | 0.30 | 0.03 | ||||||||||
Non-GAAP net income (loss) per share - basic and diluted | $ | 0.04 | $ | (0.05 | ) | $ | (0.08 | ) | $ | - | $ | (0.18 | ) | ||
Aeluma, Inc. and Subsidiary
Consolidated Statements of Cash Flows (unaudited)
Six Months Ended December 31, | ||||||
2024 | 2023 | |||||
Operating activities: | ||||||
Net loss | $ | (3,624,443 | ) | $ | (2,610,829 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Amortization of deferred compensation | 13,962 | 18,938 | ||||
Stock-based compensation expense | 316,194 | 376,496 | ||||
Depreciation and amortization expense | 202,306 | 131,783 | ||||
Amortization of discount on convertible notes | 427,819 | - | ||||
Changes in fair value of derivative liabilities | 2,855,045 | - | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | (1,264,628 | ) | (3,753 | ) | ||
Prepaids and other current assets | (114,670 | ) | (135,704 | ) | ||
Accounts payable | (134,305 | ) | (298,974 | ) | ||
Accrued expenses and other current liabilities | (9,496 | ) | 41,698 | |||
Net cash used in operating activities | (1,332,216 | ) | (2,480,345 | ) | ||
Investing activities: | ||||||
Purchase of equipment | (40,797 | ) | (164,290 | ) | ||
Net cash used in investing activities | (40,797 | ) | (164,290 | ) | ||
Financing activities: | ||||||
Repurchase of common stock | - | (4,001 | ) | |||
Proceeds from note issuance | 3,145,000 | - | ||||
Net cash provided by (used in) financing activities | 3,145,000 | (4,001 | ) | |||
Net change in cash | 1,771,987 | (2,648,636 | ) | |||
Cash, beginning of period | 1,291,072 | 5,071,690 | ||||
Cash, end of period | $ | 3,063,059 | $ | 2,423,054 | ||
SOURCE: Aeluma, Inc.
View the original press release on ACCESS Newswire
P.Hernandez--AT